Search Browse Earnings

CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.

Nasdaq:CELZ

Biological Products, (No Diagnostic Substances)·PHOENIX, AZ

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

$9,000

-89.8% YoY

FY 2024

Adj. EBITDA

-$5.6M

-61823.7% margin

FY 2024

Net Income

-$5.3M

-58739.7% margin

FY 2024

EPS (Diluted)

-$3.76

FY 2024

Stock Price

$1.90

+0.8%

2026-03-09

52W Range

$1.50 – $6.25

P/E Ratio

-0.5x

Market Cap

$4.9M

Cash

$88,648

FY 2021

Total Debt

$493,250

FY 2017

Net Debt

$404,602

FY 2017

Enterprise Value

$5.3M

Debt / EBITDA

-0.1x

FY 2024

EV / EBITDA

-1.0x

Employees

—